SFA — Sopharma AD Cashflow Statement
0.000.00%
Last trade - 00:00- €882.90m
- €1.17bn
- BGN2.64bn
Annual cashflow statement for Sopharma AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -148 | -145 | -170 | -206 | -253 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -76 | 110 | 45 | 76.7 | 18.6 |
| Capital Expenditures | -27.1 | -23.7 | -43.3 | -121 | -143 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -41 | -40 | -19.6 | 33.3 | 22.2 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -68.1 | -63.6 | -62.8 | -88.1 | -121 |
| Financing Cash Flow Items | 204 | 30.6 | -0.513 | 4.85 | 59.1 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 157 | -64.3 | 127 | -81.9 | 138 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 12.6 | -17.9 | 109 | -93.2 | 36 |